TLRs, future potential therapeutic targets for RA.

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Toll-like receptors (TLRs) are crucial for innate immunity.
• Previous research identified TLR2 and TLR4 roles in rheumatoid arthritis (RA).
• Emerging evidence suggests TLR5 and TLR7 also contribute to RA pathogenesis.

Purpose of the Study:

• To review recent data on TLR5 and TLR7 involvement in RA.
• To evaluate TLR pathogenicity across various RA cell types.
• To explore TLR-mediated mechanisms contributing to RA bone erosion.

Main Methods:

• Review of recent scientific literature on TLRs in RA.
• Analysis of TLR function in myeloid cells, fibroblasts, T cells, osteoclast progenitors, and endothelial cells.
• Examination of preclinical RA models to understand TLR-driven inflammation.

Main Results:

• TLR ligation transforms RA myeloid cells into M1 macrophages.
• Secreted factors from M1 macrophages and synovial fibroblasts promote TH-17 cell development.
• TLR-mediated inflammation links myeloid and TH-17 cells to joint vascularization and osteoclastic bone erosion.

Conclusions:

• TLR5 and TLR7 play significant roles in RA pathogenesis.
• TLR activation drives inflammatory pathways leading to bone erosion in RA.
• Novel therapeutic approaches targeting TLRs are under investigation for RA treatment.